Vanguard Capital Management »

Alzamend Neuro Inc Com New 2025 shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Alzamend Neuro Inc Com New 2025 (ALZN) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Alzamend Neuro Inc Com New 2025

Tip: Access up to 7 years of quarterly data

All positions including Alzamend Neuro Inc Com New 2025 held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alzamend Neuro Inc Com New 2025 by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7k 4.4k 1.06

More positions owned by Vanguard Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Capital Management

Top funds holding Alzamend Neuro Inc Com New 2025

Geode Capital Management
Vanguard Group
Vanguard Fiduciary Trust
Morgan Stanley
Virtu Financial
XTX Topco
Hartland & Co
Citigroup
UBS Group
Vanguard Capital Management
Tower Research Capital
BlackRock
SBI Securities
Caitong International Asset Management
Harbor Investment Advisory

View all funds holding Alzamend Neuro Inc Com New 2025